Skip to main content
Erschienen in: Virchows Archiv 3/2016

14.12.2015 | Original Article

Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions

verfasst von: Jérôme Doyen, Valérie Duranton-Tanneur, Isabelle Hostein, Marie Karanian-Philippe, Christine Chevreau, Florence Breibach, Michael Coutts, Bérengère Dadone, Marie-Christine Saint-Paul, Jean Gugenheim, Florence Duffaud, Florence Pedeutour

Erschienen in: Virchows Archiv | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Desmoid type fibromatosis (DT) is a rare lesion of unclear pathogenesis that most often presents a mutation of the (β-catenin) gene. The natural history and clinical evolution are highly variable between patients and to date there is no consensus on optimal therapy. We report two cases of a patient with multiple DT lesions. Molecular investigations performed in both patients on multiple tumors at different anatomical sites revealed non-identical CTNNB1 mutations. The first patient was a 39-year-old man with a history of recurrent DT. In two of the DT lesions, three different mutations were found in codons 41 and 45, respectively. The lesions showed marked inflammatory features, characterized by IgG4 positive lymphoplasmacytic infiltrates and a foreign body reaction, which increased in intensity over time. The patient was eventually treated with a COX-2 inhibitor and the remaining mass was stabilized. In the two DT lesions of the second patient, CTNNB1 mutations S45P and T41A were found. The presence of different mutations in multiple focally recurrent sporadic DT lesions indicates that they do not have a clonal relationship. Our data suggest that a CTNNB1 mutation is a necessary event probably by providing a selective growth advantage. An IgG4 host antigen response is discussed as a potential predisposing factor for one of the patients.
Literatur
1.
Zurück zum Zitat Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) Tumours of soft tissue and bone: pathology and genetics. In: World Health Organization classification of tumours, 4th edn. IARC Press, Lyon Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) Tumours of soft tissue and bone: pathology and genetics. In: World Health Organization classification of tumours, 4th edn. IARC Press, Lyon
2.
Zurück zum Zitat Pikaar A, Nortier JW, Griffioen G, Vasen HF (2002) Desmoid tumors in patients with familial adenomatous polyposis. Ned Tijdschr Geneeskd 146:1355–1359PubMed Pikaar A, Nortier JW, Griffioen G, Vasen HF (2002) Desmoid tumors in patients with familial adenomatous polyposis. Ned Tijdschr Geneeskd 146:1355–1359PubMed
3.
Zurück zum Zitat Bertario L, Russo A, Sala P, Varesco L, Giarola M, Mondini P et al (2003) Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 21:1698–1707CrossRefPubMed Bertario L, Russo A, Sala P, Varesco L, Giarola M, Mondini P et al (2003) Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 21:1698–1707CrossRefPubMed
5.
Zurück zum Zitat Reitamo JJ, Hayry P, Nykyri E, Saxen E (1982) The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77:665–673CrossRefPubMed Reitamo JJ, Hayry P, Nykyri E, Saxen E (1982) The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77:665–673CrossRefPubMed
6.
Zurück zum Zitat Escobar C, Munker R, Thomas JO, Li BD, Burton GV (2012) Update on desmoid tumors. Ann Oncol 23:562–569CrossRefPubMed Escobar C, Munker R, Thomas JO, Li BD, Burton GV (2012) Update on desmoid tumors. Ann Oncol 23:562–569CrossRefPubMed
7.
Zurück zum Zitat Le Guellec S, Soubeyran I, Rochaix P, Filleron T, Neuville A, Hostein I et al (2012) CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol 25:1551–1558CrossRefPubMed Le Guellec S, Soubeyran I, Rochaix P, Filleron T, Neuville A, Hostein I et al (2012) CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol 25:1551–1558CrossRefPubMed
8.
Zurück zum Zitat Tejpar S, Nollet F, Li C, Wunder JS, Michils G, Dal Cin P et al (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18:6615–6620CrossRefPubMed Tejpar S, Nollet F, Li C, Wunder JS, Michils G, Dal Cin P et al (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18:6615–6620CrossRefPubMed
9.
Zurück zum Zitat Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E et al (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173:1518–1527CrossRefPubMedPubMedCentral Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E et al (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173:1518–1527CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P et al (2010) Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes Chromosomes Cancer 49:560–568PubMed Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P et al (2010) Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes Chromosomes Cancer 49:560–568PubMed
11.
Zurück zum Zitat Grunhagen DJ, De Wilt JH, Verhoef C, Van Geel AN, Eggermont AM (2005) TNF-based isolated limb perfusion in unresectable extremity desmoid tumours. Eur J Surg Oncol 31:912–916CrossRefPubMed Grunhagen DJ, De Wilt JH, Verhoef C, Van Geel AN, Eggermont AM (2005) TNF-based isolated limb perfusion in unresectable extremity desmoid tumours. Eur J Surg Oncol 31:912–916CrossRefPubMed
12.
Zurück zum Zitat Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS et al (1997) The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 39:659–665CrossRefPubMed Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS et al (1997) The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 39:659–665CrossRefPubMed
13.
Zurück zum Zitat Harnet JC, Pedeutour F, Raybaud H, Ambrosetti D, Fabas T, Lombardi T (2013) Immunohistological features in adenomatoid odontogenic tumor: review of the literature and first expression and mutational analysis of beta-catenin in this unusual lesion of the jaws. J Oral Maxillofac Surg 71:706–713CrossRefPubMed Harnet JC, Pedeutour F, Raybaud H, Ambrosetti D, Fabas T, Lombardi T (2013) Immunohistological features in adenomatoid odontogenic tumor: review of the literature and first expression and mutational analysis of beta-catenin in this unusual lesion of the jaws. J Oral Maxillofac Surg 71:706–713CrossRefPubMed
14.
Zurück zum Zitat Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790CrossRefPubMed Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790CrossRefPubMed
15.
Zurück zum Zitat Van Broekhoven DL, Verhoef C, Grunhagen DJ, Van Gorp JM, Den Bakker MA, Hinrichs JW et al (2014) Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Ann Surg Oncol 22(5):1464–70CrossRefPubMed Van Broekhoven DL, Verhoef C, Grunhagen DJ, Van Gorp JM, Den Bakker MA, Hinrichs JW et al (2014) Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Ann Surg Oncol 22(5):1464–70CrossRefPubMed
16.
Zurück zum Zitat Mullen JT, DeLaney TF, Rosenberg AE, Le L, Iafrate AJ, Kobayashi W et al (2013) Beta-catenin mutation status and outcomes in sporadic desmoid tumors. Oncologist 18:1043–1049CrossRefPubMedPubMedCentral Mullen JT, DeLaney TF, Rosenberg AE, Le L, Iafrate AJ, Kobayashi W et al (2013) Beta-catenin mutation status and outcomes in sporadic desmoid tumors. Oncologist 18:1043–1049CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Iwama T, Kuwabara K, Ushiama M, Yoshida T, Sugano K, Ishida H (2009) Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence. Fam Cancer 8:51–54CrossRefPubMed Iwama T, Kuwabara K, Ushiama M, Yoshida T, Sugano K, Ishida H (2009) Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence. Fam Cancer 8:51–54CrossRefPubMed
18.
Zurück zum Zitat Baschinsky DY, Isa A, Niemann TH, Prior TW, Lucas JG, Frankel WL (2000) Diffuse leiomyomatosis of the uterus: a case report with clonality analysis. Hum Pathol 31:1429–1432CrossRefPubMed Baschinsky DY, Isa A, Niemann TH, Prior TW, Lucas JG, Frankel WL (2000) Diffuse leiomyomatosis of the uterus: a case report with clonality analysis. Hum Pathol 31:1429–1432CrossRefPubMed
19.
Zurück zum Zitat Agaimy A, Dirnhofer S, Wunsch PH, Terracciano LM, Tornillo L, Bihl MP (2008) Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Am J Surg Pathol 32:1553–1559CrossRefPubMed Agaimy A, Dirnhofer S, Wunsch PH, Terracciano LM, Tornillo L, Bihl MP (2008) Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Am J Surg Pathol 32:1553–1559CrossRefPubMed
20.
Zurück zum Zitat Chmara M, Wernstedt A, Wasag B, Peeters H, Renard M, Beert E et al (2013) Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency. Genes Chromosomes Cancer 52:656–664PubMed Chmara M, Wernstedt A, Wasag B, Peeters H, Renard M, Beert E et al (2013) Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency. Genes Chromosomes Cancer 52:656–664PubMed
21.
Zurück zum Zitat Stone JH (2012) IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 29:177–190CrossRefPubMed Stone JH (2012) IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 29:177–190CrossRefPubMed
22.
Zurück zum Zitat Ebbo M, Daniel L, Pavic M, Seve P, Hamidou M, Andres E et al (2012) IgG4-related systemic disease: features and treatment response in a French cohort. results of a multicenter registry Medicine (Baltimore) 91:49–56CrossRef Ebbo M, Daniel L, Pavic M, Seve P, Hamidou M, Andres E et al (2012) IgG4-related systemic disease: features and treatment response in a French cohort. results of a multicenter registry Medicine (Baltimore) 91:49–56CrossRef
Metadaten
Titel
Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions
verfasst von
Jérôme Doyen
Valérie Duranton-Tanneur
Isabelle Hostein
Marie Karanian-Philippe
Christine Chevreau
Florence Breibach
Michael Coutts
Bérengère Dadone
Marie-Christine Saint-Paul
Jean Gugenheim
Florence Duffaud
Florence Pedeutour
Publikationsdatum
14.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 3/2016
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-015-1883-8

Weitere Artikel der Ausgabe 3/2016

Virchows Archiv 3/2016 Zur Ausgabe

Editorial

In this issue

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …